Page 182 - January 2022 Issue
P. 182

Biotechnology



            Industry Research



            Assistance Council






                                                                                               Anju Bhalla
                                                                                                 MD,  BIRAC




                                                  iotechnology  Industry  Research  Assistance  Council  (BIRAC)  is  a
                                                  not-for-profit Section 8 company incorporated under the Companies
                                           BAct,  2013  and  a  Schedule  B,  Public  Sector  Enterprise,  set  up  by
                                            Department of Biotechnology (DBT), Ministry of Science & Technology,
                                            Government of India as an interface agency to strengthen and empower
                                            the emerging biotech enterprise to undertake strategic research  and
                                            innovation, addressing nationally relevant product development needs.


            DBT-BIRAC announced             BIRAC  is  an  industry-academia  interface  and  implements  its  mandate
                                            through a wide range of impact initiatives, be it providing access to risk
            a COVID-19 Research
                                            capital through targeted funding, technology transfer, IP management and
            Consortium call,
                                            handholding schemes that help bring innovation excellence to the biotech
            soliciting project              firms and make them globally competitive. In its eight years of existence,
            proposals for developing        BIRAC has initiated several schemes, networks and platforms that help to

            Diagnostics, Vaccines,          bridge the existing gaps in the industry-academia Innovation research and
            Novel Therapeutics,             facilitate novel, high quality affordable products development through
            Repurposing of Drugs or         cutting edge technologies. BIRAC has initiated partnerships with several
            any other intervention          national and global partners to collaborate and deliver the salient features
                                            of its mandate.
            for control of COVID-19
            by Industry/Academia/           Employees Strength
            Industry-Academia               BIRAC has a contract career path for its Employees. The total number of
            participation.                  employees is 49 (Forty-Nine).


















                                                                  Biotechnology Industry Research Assistance Council  155
   177   178   179   180   181   182   183   184   185   186   187